SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-032501
Filing Date
2023-05-26
Accepted
2023-05-26 16:10:23
Documents
2
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4048
2 POA DOCUMENT poa.txt EX-24 3260
  Complete submission text file 0001209191-23-032501.txt   8958
Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 (858) 453-7200
Aurentz Vincent (Reporting) CIK: 0001657494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40192 | Film No.: 23968952

Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Issuer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations